Panacea Biotec Ltd share price logo

Panacea Biotec Share Price (PANACEABIO)

Check the latest share price of Panacea Biotec, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹447.55.05%

as on 04:01PM, 06 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Panacea Biotec Stock Performance

Get live Panacea Biotec share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹442.6
    Day's Price Range
    ₹475.2
  • 52 Week's Low

    52 Week's High

    ₹112.35
    52-Week Price Range
    ₹581.9
1 Month Return-11.03 %
3 Month Return+ 19.88 %
1 Year Return+ 247.3 %
3 Year Return+ 199.13 %
5 Year Return+ 179.84 %
Previous Close₹471.30
Open₹471.30
Volume3.28L
Upper Circuit₹518.40
Lower Circuit₹424.20

Panacea Biotec Fundamentals & Key Indicators

Check Panacea Biotec market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹2,740.97 Cr

Return on Equity (ROE)

0.86

PE Ratio (TTM)

-321.94

Return on capital employed (ROCE)

3.26

Industry PE ratio

56.05

Beta (LTM)

1

P/B Ratio

2.42

Dividend Yield

0

PEG Ratio

261.74

Quarterly Earnings Growth YOY

0

EPS (TTM)

-0.25

Sector

Pharmaceuticals

Book Value

133.94

Technical Analysis

How to invest in Panacea Biotec?

Investing in Panacea Biotec is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Panacea Biotec or PANACEABIO on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Panacea Biotec or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Panacea Biotec with just a few clicks!

Panacea Biotec Stock's Interest Amongst Investors

-42%

Period Jun 08, 2025 to May 09, 2025. Change in 30 Days vs previous period

Search interest for Panacea Biotec Ltd Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Panacea Biotec Valuation

Track how Panacea Biotec P/E has moved over time to understand its valuation trends.

Panacea Biotec in the last 5 years

  • Overview

  • Trends

Lowest (-915.62x)

April 25, 2024

Today (-321.94x)

June 6, 2025

Industry (56.05x)

June 6, 2025

Highest (113.15x)

October 5, 2023

LowHigh

Today’s Price to Earnings Ratio: -321.94x

Panacea Biotec Financial Results

Get the annual and quarterly financial summary of Panacea Biotec, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

136 (0%)116 (15%)147 (27%)163 (11%)133 (19%)
Net Income

(in ₹ Cr)

-2 (0%)-16 (698%)5 (130%)4 (6%)-2 (145%)
Net Profit Margin-1.46% (0%)-13.72% (840%)3.20% (123%)2.72% (15%)-1.50% (155%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

790 (0%)834 (6%)770 (8%)800 (4%)
Total Liabilities

(in ₹ Cr)

282 (0%)419 (48%)439 (5%)465 (6%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

-83 (0%)38 (146%)-53 (238%)-11 (80%)37 (447%)

Panacea Biotec Earnings and Dividends

View detailed summary of the earnings and dividend history of Panacea Biotec.

  • Panacea Biotec Ltd Earnings Results

    Panacea Biotec Ltd’s net profit jumped 5.03% since last year same period to ₹-1.89Cr in the Q4 2024-2025. On a quarterly growth basis, Panacea Biotec Ltd has generated -141.81% fall in its net profits since last 3-months.

    Read More about Earnings Results

Panacea Biotec Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Panacea Biotec.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
72.48%
0.00
Foreign Institutions
1.16%
0.00
Mutual Funds
0%
0.00
Retail Investors
24.86%
0.00
Others
1.49%
0.00

Panacea Biotec vs Peers

Compare market cap, revenue, PE, and other key metrics of Panacea Biotec with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA2,740.9735.97%0.65NANA
NA603.841703.75%0.53NANA
NA2,065.5221.1%0.51NANA
NA93.54130.17%2.00NANA
NA274.9624.71%0.60NANA

Panacea Biotec News & Key Events

Latest news and events in one place to help you make informed investing decisions in Panacea Biotec.

  • Panacea Biotec's EmulsiPan Added to CEPI Adjuvant Library - 03 Jun, 2025

    Panacea Biotec announced the inclusion of its adjuvant EmulsiPan in the CEPI Adjuvant Library, enhancing vaccine efficacy and supporting global health initiatives. The Chairman emphasized the company's commitment to R&D.
  • Panacea Biotec Develops Promising Dengue Vaccine - 27 May, 2025

    Panacea Biotec is working on a dengue vaccine, with data expected in the next year or two. If successful, it could significantly impact the market.

Insights on Panacea Biotec Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.38% to 1.16% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.49% to 72.48% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 25.97% to 24.86% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PANACEABIO stock has moved down by -11.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 169.88 Cr → 168.83 Cr (in ₹), with an average decrease of 0.6% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 4.8 Cr → -1.89 Cr (in ₹), with an average decrease of 73.8% per quarter

About Panacea Biotec

Panacea Biotec Limited (PBL), India’s leading research-based health management company, originated in 1984 and since then has grown to become the nation’s second largest vaccine producer. Its wide range of products include innovative prescription drugs across therapeutic areas such as diabetes, renal disease, gastrointestinal, osteoporosis and antituberculosis. The company owns a number of ultra-modern, state-of-the-art production facilities that comply with USFDA, UKMHRA, SAMCA and WACGMP standards as well as four research and development centers. These are supported by collaborations and tie-ups with global industry leaders. To date, PBL owns 24 product patents valid in more than 60 countries and has forged landmark agreements on an international level. Recent collaborations include Netherland's Vaccine Institute, PT Bio Farma, The National Institute of Immunology, National Institute of Health, and Punjab University. Besides manufacturing and marketing, the company is involved in healthcare delivery, with a 220-bed multispecialty hospital, and holds a number of product patents in the US and India. PBL's step down subsidiaries Radhika Heights Limited and its subsidiaries were demerged into RVHL in 2020 and the Pharmaceutical Formulations Brands of PBPL in India and Nepal were sold to Mankind Pharma Limited in 2022. This strategic approach positions PBL at the forefront of global health management.

Revenue: ₹132.53Cr as on March 2025 (Q4 FY25)
Net Profit: ₹-1.99Cr as on March 2025 (Q4 FY25)
Listing date: 17 Apr, 1996
Chairperson Name: Rajesh Jain
OrganisationPanacea Biotec Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORajesh Jain
E-voting on sharesClick here to vote

FAQs

What is Panacea Biotec share price today?

Panacea Biotec share price today stands at ₹447.5, Open: ₹471.3, Previous Close: ₹471.3, High: ₹475.2, Low: ₹442.6, 52 Week High: ₹581.9, 52 Week Low: ₹112.35.

What is today's traded volume of Panacea Biotec?

Today's traded volume of Panacea Biotec is 3.28L. Which means that 3.28L shares of Panacea Biotec were bought and sold on the stock market during today's trading session.

What is Panacea Biotec's market cap today?

Today's market capitalisation of Panacea Biotec is ₹2,740.97 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Panacea Biotec?

Panacea Biotec’s 52 week high is ₹581.9 and 52 week low is ₹112.35. The current share price of Panacea Biotec is ₹447.5, which is -23.10% down from its 52 week high and 298.31% up from its 52 week low.